Stay updated on Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.

Latest updates to the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedRevision label on the page updated from v3.6.4 to v3.6.5, indicating a platform update rather than changes to the study details.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now displays a newer software revision, updating from v3.6.3 to v3.6.4. This reflects an updated build with no visible changes to study content or layout.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision: v3.6.3 is now shown on the page, replacing the prior v3.6.2. This indicates a platform version update rather than changes to the study data or content.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now shows Revision: v3.6.2 instead of Revision: v3.6.0, indicating a software release; the change represents a platform update rather than new or altered trial data.SummaryDifference0.1%

- Check72 days agoChange DetectedAdded recruitment status and new user guidance sections, and updated the Intervention/Treatment heading and revision version, while removing the older formatting of the heading and the older revision label.SummaryDifference0.4%

- Check79 days agoChange DetectedThe revision tag on the page was updated from v3.5.4 to v3.5.5, indicating a new version of the page. This appears to be a small, behind-the-scenes update with no changes to visible study information.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.